CAS 120202-65-5: Clopidogrel hydrochloride

Description: Clopidogrel hydrochloride is an antiplatelet medication primarily used to prevent blood clots in patients with cardiovascular diseases. It is a prodrug that requires metabolic activation to exert its therapeutic effects, primarily inhibiting the P2Y12 receptor on platelets, which plays a crucial role in platelet aggregation. The substance appears as a white to off-white crystalline powder and is soluble in water, making it suitable for oral administration. Its molecular formula includes carbon, hydrogen, nitrogen, chlorine, and oxygen, reflecting its complex structure. Clopidogrel hydrochloride is typically administered in tablet form and is often prescribed in conjunction with other medications to enhance cardiovascular protection. The pharmacokinetics of clopidogrel involve absorption in the gastrointestinal tract, followed by hepatic metabolism, which can vary among individuals due to genetic factors affecting enzyme activity. Side effects may include bleeding complications, gastrointestinal disturbances, and hypersensitivity reactions. Overall, clopidogrel hydrochloride is a vital medication in managing thrombotic disorders, contributing significantly to cardiovascular health.

Formula: C₁₆H₁₆ClNO₂S.ClH

InChI: InChI=1S/C16H16ClNO2S.ClH/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;/h2-5,7,9,15H,6,8,10H2,1H3;1H/t15-;/m0./s1

InChI key: InChIKey=XIHVAFJSGWDBGA-RSAXXLAASA-N

SMILES: Cl.O=C(OC)C(C=1C=CC=CC1Cl)N2CC=3C=CSC3CC2

Clopidogrel hydrochloride CRS

CAS: 120202-65-5

• Formula: C₁₆H₁₇Cl₂NO₂S
• Color and Shape: White. Yellowish.
• Molecular weight: 358.2827

Clopidogrel HCl

CAS: 120202-65-5

Clopidogrel HCl, a salt, inhibits platelet aggregation by blocking ADP from binding to its receptor.

• Formula: C₁₆H₁₇Cl₂NO₂S
• Color and Shape: Liquid
• Molecular weight: 358.28